Copyright
©2011 Baishideng Publishing Group Co.
World J Cardiol. Jul 26, 2011; 3(7): 219-229
Published online Jul 26, 2011. doi: 10.4330/wjc.v3.i7.219
Published online Jul 26, 2011. doi: 10.4330/wjc.v3.i7.219
Biological process | Agent | Target | Imaging platform |
Plaque rupture/thrombosis | Gadolinium carrying perfluorocarbon and peptides (EP-2104R) | Fibrin | MRI |
Phage display nanoparticles generated by CEST 99mTc-apcitide | Glycoprotein IIb/IIIa receptor | SPECT | |
Inflammation/apoptosis | MNP + specific antibodies | E-selectin | MRI |
Monocrystalline iron oxide | ICAM/VCAM | PET | |
Cross-linked iron oxide 18FDG | Macrophages glucose transporter-1, hexokinase | SPECT | |
99mTc-annexin | Phosphatidylserine/caspases | SPECT | |
99mTc-interleukin-2 | Lymphocytes | ||
Angiogenesis | MNP + specific antibody 99mNC100692 | VCAM-1/integrin αvβ3 | MRI |
Myocardial infarction | MNP 111Indium oxide | Stem cell labeling | MRI/SPECT |
- Citation: Sharif F, Lohan DG, Wijns W. Non-invasive detection of vulnerable coronary plaque. World J Cardiol 2011; 3(7): 219-229
- URL: https://www.wjgnet.com/1949-8462/full/v3/i7/219.htm
- DOI: https://dx.doi.org/10.4330/wjc.v3.i7.219